Gentle Overnight Laxative: Package Insert and Label Information

GENTLE OVERNIGHT LAXATIVE- bisacodyl tablet, delayed release
Better Living Brands, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active ingredient (in each tablet)

Bisacodyl USP, 5 mg

Purpose

Stimulant laxative

Uses

  • for relief of occasional constipation and irregularity

  • this product generally produces bowel movement in 6 to 12 hours

Warnings

Do not use

if you cannot swallow without chewing.

Ask a doctor before use if you have

  • stomach pain, nausea or vomiting
  • a sudden change in bowel habits that lasts more than 2 weeks

When using this product

  • do not chew or crush tablet(s)

  • do not use within 1 hour after taking an antacid or milk

  • you may have stomach discomfort, faintness and cramps

Stop use and ask a doctor if

  • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.

  • you need to use a laxative for more than 1 week

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

  • take with a glass of water
adults and children 12 years and over take 1 to 3 tablets in a single daily dose
children 6 to under 12 years take 1 tablet in a single daily dose
children under 6 years ask a doctor

Other information

  • TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN

  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

  • avoid excessive humidity

  • see end flap for expiration date and lot number

Inactive ingredients

acacia, ammonium hydroxide, calcium carbonate, carnauba wax, colloidal anhydrous silica, corn starch, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, iron oxide black, lactose anhydrous, magnesium stearate, methylparaben, polydextrose, polyethylene glycol, polyvinyl acetate phthalate, povidone, propylene glycol, propylparaben, shellac glaze, simethicone, sodium alginate, sodium benzoate, sodium bicarbonate, stearic acid, sucrose, talc, titanium dioxide, triacetin, triethyl citrate

Questions or comments?

1-800-426-9391

Principal display panel

Compare to
Dulcolax®
Laxative Tablets
active ingredient*

Signature
care
Quality Guaranteed

NDC 21130-827-12

Gentle
Overnight
Laxative

BISACODYL USP, 5 mg
Stimulant Laxative

• Comfort coated
• Gentle, dependable
constipation relief

Actual Size

100 TABLETS

TAMPER EVIDENT: DO NOT USE IF
PACKAGE IS OPENED OR IF BLISTER
UNIT IS TORN, BROKEN OR SHOWS
ANY SIGNS OF TAMPERING

DISTRIBUTED BY
BETTER LIVING BRANDS LLC
P.O. BOX 99, PLEASANTON, CA 94566-0009
1-888-723-3929
www.betterlivingbrandsLLC.com

OUR PROMISE
QUALITY & SATISFACTION
100% GUARANTEED
OR YOUR MONEY BACK.

*This product is not manufactured or distributed by Sanofi-Aventis Deutschland GMBH, distributors ofDulcolax® Laxative Tablets. 50844 REV0119B32712

Signature Care 44-327
(click image for full-size original)

Signature Care 44-327

GENTLE OVERNIGHT LAXATIVE bisacodyl tablet, delayed release
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:21130-827
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BISACODYL (DEACETYLBISACODYL) BISACODYL 5 mg
Inactive Ingredients
Ingredient Name Strength
ACACIA
AMMONIA
CALCIUM CARBONATE
CARNAUBA WAX
SILICON DIOXIDE
STARCH, CORN
D&C YELLOW NO. 10 ALUMINUM LAKE
FD&C YELLOW NO. 6
HYPROMELLOSE, UNSPECIFIED
FERROSOFERRIC OXIDE
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
METHYLPARABEN
POLYDEXTROSE
POLYETHYLENE GLYCOL, UNSPECIFIED
Polyvinyl Acetate Phthalate
POVIDONE, UNSPECIFIED
PROPYLENE GLYCOL
PROPYLPARABEN
SHELLAC
DIMETHICONE
WATER
SODIUM ALGINATE
SODIUM BENZOATE
SODIUM BICARBONATE
STEARIC ACID
SUCROSE
TALC
TITANIUM DIOXIDE
TRIACETIN
TRIETHYL CITRATE
Product Characteristics
Color orange Score no score
Shape ROUND Size 6mm
Flavor Imprint Code 5
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:21130-827-56 1 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK This package is contained within the CARTON (21130-827-56)
2 NDC:21130-827-12 4 BLISTER PACK in 1 CARTON contains a BLISTER PACK
2 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK This package is contained within the CARTON (21130-827-12)
3 NDC:21130-827-06 1 BOTTLE, PLASTIC in 1 CARTON contains a BOTTLE, PLASTIC
3 200 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC This package is contained within the CARTON (21130-827-06)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part334 02/03/2020
Labeler — Better Living Brands, LLC (009137209)
Establishment
Name Address ID/FEI Operations
LNK International, Inc. 038154464 manufacture (21130-827), pack (21130-827)
Establishment
Name Address ID/FEI Operations
LNK International, Inc. 832867837 manufacture (21130-827), pack (21130-827)
Establishment
Name Address ID/FEI Operations
LNK International, Inc. 832867894 manufacture (21130-827)
Establishment
Name Address ID/FEI Operations
LNK International, Inc. 967626305 pack (21130-827)
Establishment
Name Address ID/FEI Operations
LNK International, Inc. 117025878 manufacture (21130-827)

Revised: 12/2022 Better Living Brands, LLC

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.